Insider track record Other Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the detailed record of transactions filed by EcoR1 Capital Fund, L.P.. Director active across 1 company, notably LAKEFRONT BIOTHERAPEUTICS. In total, 16 filings have been logged. Activity tracked since 13 May 2025. The latest transaction was disclosed on 28 July 2025 (Purchase). Regulator: FSMA. All data is openly available.
Declarations 16 total
● Person closely associated to a member of administrative management or supervisory body · Executives · 28 Jul 2025 · LAKEFRONT BIOTHERAPEUTICS 6,336 shares @ €33.26 7.3% of flow ADR / ADS BE0003818359⌘ FSMA:galapagos-5 Ideal exit: 24 Apr 2026 (T+270) ● Person closely associated to a member of administrative management or supervisory body · Executives · 25 Jul 2025 · LAKEFRONT BIOTHERAPEUTICS 8,992 shares @ €32.36 10.0% of flow ADR / ADS BE0003818359⌘ FSMA:galapagos-40 Ideal exit: 21 Apr 2026 (T+270) ● Person closely associated to a member of administrative management or supervisory body · Executives · 24 Jul 2025 · LAKEFRONT BIOTHERAPEUTICS 16,651 shares @ €30.43 17.5% of flow ADR / ADS BE0003818359⌘ FSMA:galapagos-22 Ideal exit: 20 Apr 2026 (T+270) ● Person closely associated to a member of administrative management or supervisory body · Executives · 18 Jun 2025 · LAKEFRONT BIOTHERAPEUTICS 5,129 shares @ €28.30 5.0% of flow ADR / ADS BE0003818359⌘ FSMA:galapagos-65 Ideal exit: 15 Mar 2026 (T+270) ● Person closely associated to a member of administrative management or supervisory body · Executives · 13 Jun 2025 · LAKEFRONT BIOTHERAPEUTICS 1,755 shares @ €24.89 1.5% of flow Share BE0003818359⌘ FSMA:galapagos-17 Ideal exit: 10 Mar 2026 (T+270) ● Person closely associated to a member of administrative management or supervisory body · Executives · 13 Jun 2025 · LAKEFRONT BIOTHERAPEUTICS 4,567 shares @ €28.92 4.6% of flow ADR / ADS BE0003818359⌘ FSMA:galapagos-56 Ideal exit: 10 Mar 2026 (T+270) ● Person closely associated to a member of administrative management or supervisory body · Executives · 17 Jun 2025 · LAKEFRONT BIOTHERAPEUTICS 4,409 shares @ €28.08 4.3% of flow ADR / ADS BE0003818359⌘ FSMA:galapagos-57 Ideal exit: 14 Mar 2026 (T+270) ● Person closely associated to a member of administrative management or supervisory body · Executives · 16 Jun 2025 · LAKEFRONT BIOTHERAPEUTICS 5,422 shares @ €28.98 5.4% of flow ADR / ADS BE0003818359⌘ FSMA:galapagos-61 Ideal exit: 13 Mar 2026 (T+270) ● Person closely associated to a member of administrative management or supervisory body · Executives · 22 May 2025 · LAKEFRONT BIOTHERAPEUTICS 3,898 shares @ €28.81 3.9% of flow ADR / ADS BE0003818359⌘ FSMA:galapagos-43 Ideal exit: 16 Feb 2026 (T+270) ● Person closely associated to a member of administrative management or supervisory body · Executives · 19 May 2025 · LAKEFRONT BIOTHERAPEUTICS 626 shares @ €27.85 0.6% of flow ADR / ADS BE0003818359⌘ FSMA:galapagos-0 Ideal exit: 13 Feb 2026 (T+270) ● Person closely associated to a member of administrative management or supervisory body · Executives · 20 May 2025 · LAKEFRONT BIOTHERAPEUTICS 956 shares @ €28.81 1.0% of flow ADR / ADS BE0003818359⌘ FSMA:galapagos-42 Ideal exit: 14 Feb 2026 (T+270) ● Person closely associated to a member of administrative management or supervisory body · Executives · 13 May 2025 · LAKEFRONT BIOTHERAPEUTICS 14,192 shares @ €23.03 11.3% of flow Share BE0003818359⌘ FSMA:galapagos-33 Ideal exit: 7 Feb 2026 (T+270) ● Person closely associated to a member of administrative management or supervisory body · Executives · 16 May 2025 · LAKEFRONT BIOTHERAPEUTICS 2,612 shares @ €27.56 2.5% of flow ADR / ADS BE0003818359⌘ FSMA:galapagos-38 Ideal exit: 10 Feb 2026 (T+270) ● Person closely associated to a member of administrative management or supervisory body · Executives · 14 May 2025 · LAKEFRONT BIOTHERAPEUTICS 5,001 shares @ €26.47 4.6% of flow ADR / ADS BE0003818359⌘ FSMA:galapagos-39 Ideal exit: 8 Feb 2026 (T+270) ● Person closely associated to a member of administrative management or supervisory body · Executives · 13 May 2025 · LAKEFRONT BIOTHERAPEUTICS 10,068 shares @ €26.36 9.2% of flow ADR / ADS BE0003818359⌘ FSMA:galapagos-49 Ideal exit: 7 Feb 2026 (T+270) ● Person closely associated to a member of administrative management or supervisory body · Executives · 15 May 2025 · LAKEFRONT BIOTHERAPEUTICS 12,520 shares @ €26.75 11.6% of flow ADR / ADS BE0003818359⌘ FSMA:galapagos-37 Ideal exit: 9 Feb 2026 (T+270) About EcoR1 Capital Fund, L.P. EcoR1 Capital Fund, L.P. is a declarant linked to LAKEFRONT BIOTHERAPEUTICS, with 16 filings in total. Across the 16 sampled filings, all were purchases, for a total of EUR 2,898,939, between 2025-05-20 and 2025-07-31.